12 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 34345437 | A retrospective analysis of changes in lymphocyte levels in patients with multiple sclerosis during and after Tecfidera® treatment. | 2021 Jul-Sep | 2 |
2 | 34849598 | Dimethyl fumarate treatment restrains the antioxidative capacity of T cells to control autoimmunity. | 2021 Nov 29 | 1 |
3 | 31675639 | Dimethyl fumarate therapy reduces memory T cells and the CNS migration potential in patients with multiple sclerosis. | 2020 Jan | 3 |
4 | 32371548 | Dimethyl fumarate suppresses granulocyte macrophage colony-stimulating factor-producing Th1 cells in CNS neuroinflammation. | 2020 Jul | 1 |
5 | 32440353 | Effect of dimethyl fumarate on lymphocyte subsets in patients with relapsing multiple sclerosis. | 2020 Apr-Jun | 1 |
6 | 31066225 | Optimal response to dimethyl fumarate is mediated by a reduction of Th1-like Th17 cells after 3 months of treatment. | 2019 Sep | 1 |
7 | 30038789 | DNA methylation changes in CD4+ T cells isolated from multiple sclerosis patients on dimethyl fumarate. | 2018 Jul-Sep | 2 |
8 | 30263146 | The effect of disease modifying therapies on CD62L expression in multiple sclerosis. | 2018 Jul-Sep | 1 |
9 | 28258191 | Dimethyl Fumarate Selectively Reduces Memory T Cells and Shifts the Balance between Th1/Th17 and Th2 in Multiple Sclerosis Patients. | 2017 Apr 15 | 3 |
10 | 28377940 | Dimethyl fumarate-induced lymphopenia in MS due to differential T-cell subset apoptosis. | 2017 May | 5 |
11 | 29141823 | Delayed lymphocyte re-population following discontinuation of dimethyl fumarate and after switching to other disease modifying drug therapies. | 2017 Nov | 3 |
12 | 26767188 | Dimethyl fumarate treatment alters circulating T helper cell subsets in multiple sclerosis. | 2016 Feb | 6 |